← 홈

CGT

1,235개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,235개
CGTBiologicstaleHan weidongPhase 2

Decitabine-primed Tandem CAR19/20 engineered T cells (Decitabine-primed Tandem CAR19/20 engineered T cells)

Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 2상태 RECRUITING
CGTBiologicstaleImmune Design, a subsidiary of …Phase 1

Dendritic Cell-targeting Lentiviral Vector ID-LV305 (Dendritic Cell-targeting Lentiviral Vector ID-LV305)

HLA-A*0201 Positive Cells Present; NY-ESO-1 Positive Tumor Cells Present · HLA-A*0201 Positive Cells Present

#HLA-A0201PositiveCellsPresent#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 2상태 ACTIVE
CGTBiologicstaleCartesian TherapeuticsPhase 2

Descartes-08 (Descartes-08)

Multiple Myeloma · Antisynthetase Syndrome

#AntisynthetaseSyndrome#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 2상태 RECRUITING
CGTBiologicstaleNanjing Legend Biotech Co.Phase 2

Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy (Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy)

Lymphoma, B-Cell · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 2상태 ACTIVE
CGTBiologicstaleBeijing BiotechPhase 2

Dual-target CAR-NK cells (Dual-target CAR-NK cells)

Malignant Glioma; High-Grade Gliomas · Malignant Glioma

#MalignantGlioma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 2상태 RECRUITING
CGTBiologicstaleTScan Therapeutics, Inc.Phase 2

E7 TCR (E7 TCR)

Papillomavirus Infections; Oropharyngeal Neoplasms · Cervical Intraepithelial Neoplasia

#CervicalIntraepithelialNeoplasia#CGT#Phase2#세포유전치료#CAR-T+4
효능 ORR 5%임상시험 2상태 DISCONTINUED
CGTBiologicstaleChristian HinrichsPhase 2

E7 TCR-T cells (E7 TCR-T cells)

HPV-Associated Cervical Carcinoma; HPV-Related Carcinoma · HPV-Associated Cervical Carcinoma

#HPV-AssociatedCervicalCarcinoma#CGT#Phase2#세포유전치료#CAR-T+3
효능 ORR 5%임상시험 2상태 RECRUITING
CGTBiologicstaleRui Therapeutics Co., LtdPhase 1

Fludarabine + Cyclophosphamide + CAR-NK-CD19 Cells (Fludarabine + Cyclophosphamide + CAR-NK-CD19 Cells)

Acute Lymphoblastic Leukemia; Chronic Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
효능 ORR 0%임상시험 2상태 ACTIVE
CGTBiologicstaleNanoscope Therapeutics Inc.Phase 2

Gene Therapy product:vMCO-I (Gene Therapy product:vMCO-I)

Retinitis Pigmentosa; Retinal Diseases · Retinitis Pigmentosa

#RetinitisPigmentosa#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 2상태 ACTIVE
CGTBiologicstaleHRYZ Biotech Co.Phase 1

HRYZ-T101 TCR-T Cell (HRYZ-T101 TCR-T Cell)

Cervical Cancer; Head and Neck Squamous Cell Carcinoma · Cervical Cancer

#CervicalCancer#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 2상태 ACTIVE
CGTBiologicstaleBeijing Immunochina Medical Sci…Phase 2

IM19 CAR-T cells (IM19 CAR-T cells)

NHL · Leukemia

#Leukemia#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 2상태 ACTIVE
CGTBiologicstaleUniversity College, LondonPhase 1

4G7-CARD T-cells (Infusion of modified CAR19 T-cells, Infusion of modified CAR19 T-cells (4G7-CARD T-cells))

CD19+ Malignancies: Relapse Post-allogeneic Transplant · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
효능 ORR 77.3%임상시험 2상태 ACTIVE
CGTBiologicstaleShenzhen Geno-Immune Medical In…Preclinical

Intrathecal and intravenous LV gene therapy (Intrathecal and intravenous LV gene therapy)

X-linked Adrenoleukodystrophy · Metachromatic Leukodystrophy (MLD)

#MetachromaticLeukodystrophyMLD#CGT#Preclinical#세포유전치료#CAR-T+3
임상시험 2상태 RECRUITING
CGTBiologicstaleJuno Therapeutics, a Subsidiary…Phase 2

JCARH125 (JCARH125)

Non Hodgkin Lymphoma; Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#CGT#Phase2#세포유전치료#CAR-T+3
효능 ORR 42.9%임상시험 2상태 ACTIVE
CGTBiologicstaleChristian HinrichsPhase 1

KK-LC-1 TCR-T cells (KK-LC-1 TCR-T cells)

Gastric Cancer; Breast Cancer · Gastric Cancer

#GastricCancer#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 2상태 RECRUITING
CGTBiologicstaleNanjing Legend Biotech Co.Phase 1

LCAR-AIO T cells (LCAR-AIO T cells)

Multiple Sclerosis (MS); Neuromyelitis Optica Spectrum Disease (NMOSD) · Systemic Lupus Erythematosus (SLE)

#SystemicLupusErythematosusSLE#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 2상태 RECRUITING
CGTBiologicstaleSeigo NishidaPhase 1

Liver NK cell inoculation (Liver NK cell inoculation)

Liver Cirrhosis; Hepatocellular Carcinoma · Liver Cirrhosis

#LiverCirrhosis#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 2상태 ACTIVE
CGTBiologicstaleAnhui Kecheng intelligent healt…Phase 2

METR-NK cell（metabolic remodeling nature killer cells） (METR-NK cell（metabolic remodeling nature killer cells）)

Ovarian Cancer · Ovary Cancer

#OvaryCancer#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 2상태 RECRUITING
CGTBiologicstaleGuangdong Xiangxue Precision Me…Phase 2

NY-ESO-1（TCR Affinity Enhancing Specific T cell Therapy） (NY-ESO-1（TCR Affinity Enhancing Specific T cell Therapy）)

Soft Tissue Sarcoma · Bone Sarcoma

#BoneSarcoma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 2상태 ACTIVE
CGTBiologicstaleOriCell Therapeutics Co., Ltd.Phase 2

OriCAR-017 (OriCAR-017)

Relapsed and/or Refractory Multiple Myeloma · Neoplasms, Plasma Cell

#NeoplasmsPlasmaCell#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 2상태 RECRUITING

18 / 62 페이지

← 이전다음 →